4.135
price up icon3.89%   0.155
after-market アフターアワーズ: 4.14 0.005 +0.12%
loading

Candel Therapeutics Inc (CADL) 最新ニュース

pulisher
Nov 20, 2024

HC Wainwright Issues Pessimistic Estimate for CADL Earnings - MarketBeat

Nov 20, 2024
pulisher
Nov 20, 2024

Analysts Issue Forecasts for CADL Q4 Earnings - Defense World

Nov 20, 2024
pulisher
Nov 20, 2024

HC Wainwright Reaffirms Buy Rating for Candel Therapeutics (NASDAQ:CADL) - Defense World

Nov 20, 2024
pulisher
Nov 19, 2024

What is HC Wainwright's Forecast for CADL Q4 Earnings? - MarketBeat

Nov 19, 2024
pulisher
Nov 18, 2024

Candel Therapeutics Advances in Cancer Trials Amid Financial Challenges - TipRanks

Nov 18, 2024
pulisher
Nov 18, 2024

HC Wainwright Reaffirms "Buy" Rating for Candel Therapeutics (NASDAQ:CADL) - MarketBeat

Nov 18, 2024
pulisher
Nov 17, 2024

Candel Therapeutics, Inc. (NASDAQ:CADL) Short Interest Update - MarketBeat

Nov 17, 2024
pulisher
Nov 15, 2024

Candel Therapeutics Inc (CADL) Quarterly 10-Q Report - Quartzy

Nov 15, 2024
pulisher
Nov 14, 2024

Candel Therapeutics CEO anticipates 'paradigm shift' in prostate cancer treatment as Q3 work wraps up - Proactive financial news

Nov 14, 2024
pulisher
Nov 14, 2024

Candel Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights - The Manila Times

Nov 14, 2024
pulisher
Nov 14, 2024

Candel Therapeutics Reports $10.6M Q3 Loss, Advances Key Cancer Drug Trials for Q4 2024 | CADL Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 12, 2024

Insiders Could Have Profited By Holding onto Candel Therapeutics Shares Despite 10% Drop - Simply Wall St

Nov 12, 2024
pulisher
Nov 09, 2024

Candel Therapeutics’ CAN-3110 offers new hope for melanoma treatment – ICYMI - Proactive Investors USA

Nov 09, 2024
pulisher
Nov 07, 2024

CADLCandel Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Nov 07, 2024
pulisher
Nov 07, 2024

Candel Therapeutics CEO to present at Jefferies London healthcare conference - Proactive Investors UK

Nov 07, 2024
pulisher
Nov 07, 2024

Candel Therapeutics to Present at Jefferies London Healthcare Conference 2024 - GlobeNewswire

Nov 07, 2024
pulisher
Nov 07, 2024

Candel Therapeutics (NASDAQ:CADL) Shares Up 2.5%Should You Buy? - MarketBeat

Nov 07, 2024
pulisher
Nov 06, 2024

Candel Therapeutics presents preclinical data with CAN-3110 in Melanoma model at SITC annual Meeting - Proactive Investors USA

Nov 06, 2024
pulisher
Nov 06, 2024

Candel Therapeutics to Present Preclinical Data at SITC - GlobeNewswire

Nov 06, 2024
pulisher
Nov 05, 2024

Candel Therapeutics eyes new indication for CAN-3110 in melanoma following positive preclinical results - Proactive Investors UK

Nov 05, 2024
pulisher
Nov 05, 2024

Candel Therapeutics to Present Preclinical Data at SITC Annual Meeting Showing Promise for CAN-3110 in Melanoma, Signaling Potential Indication Expansion Beyond Recurrent High-Grade Glioma - StockTitan

Nov 05, 2024
pulisher
Nov 04, 2024

Nfi Group Inc. (NFI-T) QuotePress Release - The Globe and Mail

Nov 04, 2024
pulisher
Nov 01, 2024

Candel Therapeutics: A Low-Price Oncolytic Virus Play Further Along Than You Think - Seeking Alpha

Nov 01, 2024
pulisher
Oct 29, 2024

Candel Therapeutics Advances in Cancer Treatment Trials - Yahoo Finance

Oct 29, 2024
pulisher
Oct 29, 2024

Candel Therapeutics Showcases Innovative Cancer Therapy - GlobeNewswire

Oct 29, 2024
pulisher
Oct 28, 2024

Candel Therapeutics Showcases Innovative Cancer Therapy Candidates at 16th Annual International Oncolytic Virotherapy Conference (IOVC) - StockTitan

Oct 28, 2024
pulisher
Oct 26, 2024

Candel Therapeutics Prices IPO At $8/Share - RTTNews

Oct 26, 2024
pulisher
Oct 26, 2024

Where are the Opportunities in (CADL) - Stock Traders Daily

Oct 26, 2024
pulisher
Oct 18, 2024

Candel Therapeutics Poised for Breakthrough in Cancer Therapies, Key Trials to Read Out by Year-End - Proactive Investors Australia

Oct 18, 2024
pulisher
Oct 17, 2024

Candel Therapeutics Share PriceCADL, RNS News, Articles, Quotes, & Charts (NASDAQ:CADL) - Proactive Investors USA

Oct 17, 2024
pulisher
Oct 15, 2024

(CADL) Trading Advice - Stock Traders Daily

Oct 15, 2024
pulisher
Oct 15, 2024

Candel Therapeutics, Inc. (NASDAQ:CADL) Major Shareholder Estuardo Aguilar-Cordova Sells 15,000 Shares - MarketBeat

Oct 15, 2024
pulisher
Oct 15, 2024

Candel therapeutics investor sells $243,834 in stock By Investing.com - Investing.com South Africa

Oct 15, 2024
pulisher
Oct 10, 2024

Banxa Holdings Inc (BNXAF) QuotePress Release - The Globe and Mail

Oct 10, 2024
pulisher
Oct 05, 2024

How To Trade (CADL) - Stock Traders Daily

Oct 05, 2024
pulisher
Oct 04, 2024

Candel Therapeutics to Present Preclinical Data on Therapeutic Potential of CAN-3110 in Melanoma at SITC 2024 Annual Meeting - The Manila Times

Oct 04, 2024
pulisher
Oct 04, 2024

Candel Therapeutics to Present Preclinical Data on - GlobeNewswire

Oct 04, 2024
pulisher
Oct 04, 2024

Candel therapeutics insider sells shares worth over $240k By Investing.com - Investing.com South Africa

Oct 04, 2024
pulisher
Oct 04, 2024

Candel therapeutics insider sells shares worth over $240k - Investing.com India

Oct 04, 2024
pulisher
Oct 03, 2024

Candel Therapeutics, Inc. (NASDAQ:CADL) Major Shareholder Estuardo Aguilar-Cordova Sells 1,800 Shares - MarketBeat

Oct 03, 2024
pulisher
Sep 24, 2024

Citigroup Raises Cogent Biosciences (NASDAQ:COGT) Price Target to $15.00 - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Citi raises Cogent price target on bezuclastinib potential - Investing.com India

Sep 24, 2024
pulisher
Sep 24, 2024

Deeper Dive: Understanding Cg Oncology Inc. (CGON) Through its Various Ratios - The Dwinnex

Sep 24, 2024
pulisher
Sep 24, 2024

(CADL) Proactive Strategies - Stock Traders Daily

Sep 24, 2024
pulisher
Sep 24, 2024

Gaining Ground: Cogent Biosciences Inc (COGT) Closes Lower at 10.65, Down -3.01 - The Dwinnex

Sep 24, 2024
pulisher
Sep 24, 2024

Cg Oncology Inc. [CGON] Stock sold by Insider Song Hong Fang for $23.0 million - Knox Daily

Sep 24, 2024
pulisher
Sep 24, 2024

Capricor Therapeutics Shares Rise in Premarket on Plans to File Application for Deramiocel - MarketWatch

Sep 24, 2024
pulisher
Sep 24, 2024

Cintas Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts - Benzinga

Sep 24, 2024
pulisher
Sep 24, 2024

Farallon Capital Management LLC Decreases Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Kayne Anderson Rudnick Investment Management LLC Trims Holdings in Copart, Inc. (NASDAQ:CPRT) - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Circassia Pharmaceuticals Announces Strong H1 2024 Results - TipRanks

Sep 24, 2024
pulisher
Sep 23, 2024

Cadence Design Systems Inc. stock rises Monday, still underperforms market - MarketWatch

Sep 23, 2024
pulisher
Sep 23, 2024

Xponance Inc. Has $24.15 Million Holdings in Cadence Design Systems, Inc. (NASDAQ:CDNS) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Hood River Capital Management LLC Has $13.71 Million Holdings in Cadence Design Systems, Inc. (NASDAQ:CDNS) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Mizuho recommends buying Corbus following its drop post-Novo's obesity data (NASDAQ:CRBP) - Seeking Alpha

Sep 23, 2024
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
大文字化:     |  ボリューム (24 時間):